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INTRODUCTION
Hepatitis A is generally an acute, self-limiting infection of
the liver by an enterically transmitted picornavirus, the hep-
atitis A virus (HAV) [1]. Hepatitis A occurs worldwide, but
its prevalence is closely related to hygiene, sanitary conditions
and other indicators of a developed country. Although the
effective method for controlling enteric infections including
hepatitis A is to improve standards of hygiene and sanitation
[2], HAV vaccinations have been included in the National Im-
munization Programs (NIPs) of several developed countries
to reduce the number of severe clinical cases in young adults
by enough herd immunity [3]. In Korea, hepatitis A did not
seem to be a serious disease before 1990 because of the nat-
ural immunity derived from hepatitis A infection. Since the
mid-1990s, however, the incidence of clinical hepatitis A in
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young adults has increased. In 2008, 7,895 cases of hepatitis
A were detected by sentinel surveillance, which is 3.5 times
higher than the number of cases reported in 2007. According
to health insurance data, the incidence of HAV was 65.3 cases
per 100,000 in 2008, which is 2.3 times higher than the 28.7
cases per 100,000 reported in 2007 (author’s study, unpub-
lished data). 
Several papers reported this epidemiological shift in the
HAV and called for a hepatitis A vaccination in Korea [4, 5].
Since 1997, four inactivated hepatitis A vaccines have been
licensed in Korea; Havrix (GlaxoSmithKline Biologicals, Rix-
ensart, Belgium) and VAQTA (Merck & Co., Inc., PA, USA)
have been approved for use in the United States, and AVAX-
IM (Sanofi Pasteur, Lyon, France) and Epaxal (Berna Biotech
Ltd., Bern, Switzerland) are licensed in Europe, Canada and
several other countries [6]. Havrix and VAQTA are the most
used in Korea, but VAQTA has not been used since 2008. In
the United States, hepatitis A vaccines were administered to
high-risk children in 1996, and in 1999 were included in rou-
tine immunization programs in 11 states. They were included
in the NIP in 2006 [7]. In Korea, the hepatitis A vaccination
is not part of the NIP, and no data exist on the vaccination
coverage and the factors related to having a child vaccinated.
We report the hepatitis A vaccination rate based on a popu-
lation-based survey of 12-35-month-old children conducted
in 2005 in an area with both urban and rural populations. We
also present barriers for hepatitis A immunization and dis-
cuss the implications for identifying barriers associated with
immunization.
MATERIALS AND METHODS
Study population
The population-based survey was carried out between Fe-
bruary and April 2005 in Nonsan city. Nonsan has both urban
and rural populations, and has a low rate of migration. The
target population was 2,188 12-35-month-old children living in
Nonsan. The interview survey was completed for 1,561 chil-
dren (71.3%) and of those 68 did not keep vaccination records;
therefore, 1,493 children were included in the analysis. Inter-
viewers were students from medical school or school of public
health, who were trained on the study objectives and inter-
viewing methods. We sent a letter to the study subjects before
the survey and visited their house. When we could not meet
the subjects after three visits, we ascertained the subjects’ whe-
reabouts by neighbours or representatives of the town. Many
of them did not reside in the town or were living in facilities
for orphans or the poor. The primary caregivers of all the chil-
dren were interviewed and gave written informed consent.
Vaccination history and analysis
When a vaccination card was available, the interviewer tran-
scribed all immunization doses and dates to a standardized
recording form. A report from recall was not accepted with-
out a vaccination card or confirmation from a health provider.
During analysis, vaccination rates were split by age group (12-
23 months and 24-35 months) and odds ratios (ORs) were ad-
justed because the vaccination rate can be increased by age.
For the economic status, we asked the subjective question
“which category is appropriate for your economic status?”.
When the answers were ‘very rich’ or ‘rich’ they were classi-
fied as ‘high’ economic status, ‘ordinary’ as ‘medium’ and
‘poor’ or ‘very poor’ as ‘low’.
For health security, we checked the health insurance or medi-
cal aid card and the numbers for confirmation.
Chi-square tests were used to compare rates, and a multi-
ple logistic regression model included all variables that were
statistically significant in a univariate analysis except confound-
ing variables. All analyses were conducted using SPSS Ver.
14.0 (SPSS Inc., Chicago, USA).
RESULTS
The hepatitis A immunization rate for children aged 12-35
months was 42.3% for ≥1 dose and 24.7% for 2-dose. Among
children 24-35 months of age, the rates for ≥1 dose and 2-
dose were 45% and 35.2%, respectively. The immunization
rate was significantly lower in rural areas (47.1% for urban
areas and 36.7% for rural areas for ≥1 dose), late birth order
(53.0% for the first child, 39.2% for the second child and 24.2
% for the third and successive children for ≥1 dose, and 33.0
%, 21.9% and 11.7% for 2-dose, respectively), large number
of siblings (50.5% for no siblings, 44.0% for one sibling and
26.6% for two or more siblings for ≥1 dose, and 28.7%, 27.0
% and 12.9% for 2-dose, respectively) and when the primary
caregiver was not the parent (43.6% for parent and 35.2%
for others for ≥1 dose, and 25.9% and 18.8% for 2-dose,
respectively). No significant difference in the immunization
rate was found for gender (Table 1).
The hepatitis A immunization rate was significantly lower
in children whose parents had a low economic status for ≥1
dose (p<0.001) and 2-dose (p=0.004). Mothers who were
employed and those who unmarried were significantly less
likely to have their children vaccinated for ≥1 dose (p=0.002
and p=0.034, respectively; Table 2). The parents’ level of health
security was borderline significant, and the mother’s level of
education did not significantly influence whether a child was
vaccinated.
The hepatitis A immunization rate was significantly lowerin children who had not received other childhood vaccinations.
Children who were not immunized against measles-mumps-
rubella (MMR) received HAV vaccination 2.8 times less often
for ≥1 dose and 7.3 times less often for 2-dose. MMR vacci-
nees immunized at a public health center were less likely to
be immunized against hepatitis A than children immunized at
a private clinic (29.8% for a public health centre and 71.0%
for a private clinic for ≥1 dose of hepatitis A, and 15.7% and
47.4% for 2-dose, respectively (data not shown).
Children who were not immunized against varicella were
also not immunized against the HAV 20.2 times more for ≥
1 dose and 22.0 times more for 2-dose. In comparison with
the children who had received the Haemophilus influenza
type b (Hib) vaccination of ≥1 dose, the children who had
received no Hib vaccination were at risk of no immunization
against hepatitis A (OR=14.3 for ≥1 dose and OR=13.3 for
2-dose Table 3).
The result of the age-adjusted logistic regression model was
similar to the multivariate model; the multivariate model in-
cluded age, birth order, economic status, geographical area
and mother’s employment status. The analysis revealed that
the second child (OR=1.6) and the third or successive child
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*p value obtained by 
2 test.
≥1 dose 2-dose
Vaccination p value* Vaccination p value*
rate (%) rate (%)
Characteristics (n)
Table 1. Vaccination rate of hepatitis A by general characteris-
tics of children in Nonsan, 2005
Gender
Male (777) 41.3 24.3
Female (716) 43.3 0.438 25.1 0.715
Child’s age (month)
12-23 (724) 39.4 13.5
24-35 (769) 45.0 0.028 35.2 <0.001
Geographical area
Urban (803) 47.1 26.4
Rural (690) 36.7 <0.001 22.8 0.103
Birth order
First (606) 53.0 33.0
Second (636) 39.2 21.9
Third+ (248) 24.2 <0.001 11.7 <0.001
Missing (3) --
No. of sibling
0 (418) 50.5 28.7
1 (777) 44.0 27.0
2+ (286)  26.6 <0.001 12.9 <0.001
Missing (12) --
Primary caregiver
Parent (1,233) 43.6 25.9
Other (256) 35.2 0.012 18.8 0.016
Missing (4) --
Total (1,493) 42.3 24.7
*p value obtained by 
2 test.
≥1 dose 2-dose
Vaccination p value* Vaccination p value*
rate (%) rate (%)
Characteristics (n)
Table 2. Vaccination rate of hepatitis A by general characteris-
tics of subject’s parents in Nonsan, 2005
Economic status
Low (207) 29.5 16.9
Medium+ (1,267) 44.4 <0.001 26.1 0.004
Missing (19) --
Mother’s employment
No (1059) 45.0 26.3
Yes (357) 35.6 0.002 22.7 0.181
Missing (77) --
Marital status
Married (1,431) 42.6 24.7
Others (36) 25.0 0.034 16.7 0.226
Missing (26) --
Health security
Health insurance 42.8 25.1
(1,435)
Medical aid (50) 30.0 0.072 16.0 0.143
Missing (8) --
Mother’s education
≤High school (928) 40.9 25.1
≥College (541) 45.1 0.120 24.8 0.885
Missing (24) --
Total (1,493) 42.3 24.7
OR, odds ratio; CI, confidence interval.
*Children who have vaccination one dose or more.
Vaccination rate Age-adjusted
of hepatitis A (%) OR (95% CI)
≥1 dose 2-dose ≥1 dose 2-dose
Vaccine (n)
Table 3. Vaccination rate and risk for non-vaccination of hepati-
tis A by other vaccinations in Nonsan, 2005
MMR
Yes (1,362)* 44.3 26.7 1.0 1.0
No (131) 21.4 3.8 2.8 (1.8-4.3) 7.3 (3.0-18.2)
Varicella
Yes (1,108)* 55.0 32.5 1.0 1.0
No (385) 5.7 2.3 20.2 (12.9-31.5) 22.0 (11.2-43.3)
Haemophilus influenza type b
Yes (793)* 68.1 41.5 1.0 1.0
No (700) 13.0 5.7 14.3 (11.0-18.7) 13.3 (9.3-19.1)4
(OR=3.3) were less often immunized than the first child for
≥1 dose of hepatitis A. Low economic status (OR=1.6), rural
residence (OR=1.5) and an employed mother (OR=1.5) were
significantly decreased for ≥1 dose of the hepatitis A vacci-
nation. The ORs for birth order and economic status for 2-
dose were similar to those for ≥1 dose; however, geographi-
cal area and mother’s employment status were not significant
for 2-dose (Table 4).
DISCUSSION
The immunization rate for hepatitis A among 12-35-month-
old Korean children was low: 42.3% for ≥1 dose and 24.7%
for 2-dose. Our data indicate that the immunization rate for
hepatitis A is significantly lower than that for vaccines part of
the NIP, such as MMR (91.2%) and varicella (74.2%, the vac-
cine was included in the NIP in 2005) [8]. Hib is excluded from
the NIP, but the immunization rate for one or more dose was
53.1%, higher than that for hepatitis A.
The hepatitis A vaccine coverage (two doses) in Korea has
been estimated to be 41.6% based on the amount of hepati-
tis A vaccine sold between 1998 and 2006 [9]. However, this
study did not account for vaccine doses that were unused and
immunization in other age groups, and the figure could be an
overestimate.
In 2006, the seroprevalence of the HAV was reported to be
55.6% in children aged 1-4 yr and 47.2% in those aged 5-9
yr [10]. In general, 90-100% of children one year of age and
older and adults had protective concentrations of the anti-
body four weeks after one dose of the vaccination [6]. Anti-
HAV has been shown to persist for at least 10-12 yr after vac-
cination in 5-6-yr-old children [11, 12]. The seropositive rate
of hepatitis A was 10.1% (34/337) for 10-24-yr-olds born
between 1984 and 1996, i.e., before the hepatitis A vaccine
was introduced in Korea, 27.1% for people aged 25-29 yr,
73.2% for 30-39-yr-olds and 96% for 40-49-yr-olds [10]. This
means that since the mid-1980s the natural infection rate of
hepatitis A has been less than 10% in Korea. Therefore, most
Korean children aged 1-9 yr who are immune to hepatitis A
received immunity from a vaccination, and natural immunity
through a hepatitis A infection is likely to be less than 10%.
In the United States in 2003, vaccination coverage of ≥1
dose was 50.9% for children living in the 11 states in which
routine hepatitis A vaccination is recommended, 25% for those
living in the six states in which hepatitis A vaccination is con-
sidered and 1.4% for the 33 states without a specific recom-
mendation [13]. Israel was the first country worldwide to im-
plement a universal HAV immunization program in which
toddlers born after 1997 received two doses of the HAV vac-
cine at 18 and 24 months [14]. Overall vaccine coverage in the
first years after implementation of the program (2001-2002)
was ~90% for ≥1 dose and ~85% for 2-dose [14]. In the birth
cohort of 2000 in southern Israel, HAV vaccine coverage was
85.5% for ≥1 dose and 74.9% for 2-dose by age three [15].
If the hepatitis A vaccination was recommended as a routine
immunization in Korea and free vaccinations were offered at
a public health center, vaccination coverage would increase
to the level of the NIP vaccines.
In this study, birth order was the factor most highly corre-
lated with hepatitis A vaccination rate. The first child had the
highest rate of vaccination followed by the second and then
the third and successive children. This finding agrees with other
studies on birth order and immunization rates [16, 17]. Birth
order might be a proxy parameter of a parent’s concern for
the child. In this study, economic status was also related to
Epidemiology and Health 2009;31:e2009003
Birth order (first)
Second 1.7 (1.4-2.2) 1.8 (1.4-2.3) 1.6 (1.3-2.1) 1.8 (1.3-2.3)
Third+ 3.5 (2.5-4.9) 3.9 (2.5-6.0) 3.3 (2.3-4.6) 3.7 (2.4-5.8)
Economic status (medium+)
Low 1.9 (1.4-2.6) 1.7 (1.2-2.6) 1.6 (1.2-2.3) 1.6 (1.0-2.4)
Geographical area (urban)
Rural 1.5 (1.3-1.9) 1.3 (1.0-1.6) 1.5 (1.2-1.8) 1.3 (0.9-1.7)
Mother’s employment (no)
Yes 1.5 (1.2-1.9) 1.3 (1.0-1.7) 1.5 (1.2-2.0) 1.2 (0.9-1.5)
Age adjusted OR (95% CI) Multivariate adjusted* OR (95% CI)
≥1 dose 2-dose ≥1 dose 2-dose
Variables (reference)
OR, odds ratio; CI, confidence interval.
*Logistic regression model included age, birth order, economic status, geographical area and mother’s employment.
Table 4. Risk factors for non-vaccination of hepatitis A in Nonsan, 2005vaccination rate. A hepatitis A vaccination administered in a
private clinic is expensive (about $40 for a single dose), and
cost is a well-known barrier to immunization [18]. Geographi-
cal area was also significantly related to immunization rate:
the rate was lower in rural than in urban areas. Because hep-
atitis A is excluded from the NIP, it is only offered in private
clinics, which are more common in urban areas. Furthermore,
private clinics are less accessible in rural areas, where the trans-
portation system is less convenient. The barriers for immuniza-
tion of hepatitis A can be different to other vaccinations in the
NIP. In this survey, the significant risk factors for immuniza-
tion of the NIP were birth order, primary caregiver, mother’s
employment and marital status; economic status and geographi-
cal area were not related to the immunization of the NIP [8].
In the United States, the coverage rate of hepatitis A was high-
er among children living in urban areas whatever vaccination
policy (recommended, considered and not recommended) [13],
and in metropolitan areas [19].
Children of employed mothers had a lower vaccination rate,
perhaps because those mothers had less time to go to clinics to
obtain information about the HAV or to have their children
immunized against it. The univariate analysis indicated that
the immunization rate was lower when the primary caregiv-
er was not a parent. However, when it was stratified by the
mother’s employment status, the primary caregiver was no
longer significant and mother’s employment status was found
to be a confounding factor (Table 5). Therefore, the primary
caregiver factor was excluded from the multivariate analysis.
The risk factors associated with low immunization cover-
age can be divided into two groups: parental factors such as
poverty, low education and lack of parental care, and provider
factors such as health care facility, public health system pro-
vision of free vaccines and vaccination policy [18].
This is the first report on the factors associated with the hep-
atitis A immunization rate in Korea. Our data, however, are
derived from one area and thereby are not representative of
the entire country. The vaccination histories were based on
information taken from vaccination cards. Children without
a vaccination record were excluded and many of them were
institutionalized; therefore, we might have overestimated the
immunization rate.
The WHO suggests that hepatitis A immunization is a cost
effective public health tool to control the disease in countries
where clinical hepatitis A is a major health problem [20]. The
incidence of clinical hepatitis A has recently increased sharply
in Korea, and we recommend that the hepatitis A vaccina-
tion be included in the NIP. To control the high incidence of
hepatitis A in 20-39 yr-olds in Korea, catch-up immunization
might also be considered. 
In this study, late birth order (less parental concern), low eco-
nomic status (high cost of vaccination), rural area (low acces-
sibility to a private clinic) and the mother’s employment (moth-
er’s time commitments) decreased the hepatitis A vaccination
rate. The cost and accessibility factors could be alleviated if
the hepatitis A vaccination was included in the NIP. However,
parental concern and mother’s time commitments will continue
to affect the hepatitis A immunization rate. Therefore, a vac-
cination policy that can overcome these barriers should be de-
veloped and implemented to increase the immunization rate.
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CI, confidence interval.
Mother’s employment Primary caregiver Relative prevalence (95% CI)
Yes Parent 62 (36.0) 110 (64.0) 36.0%/34.6%=1.0 (0.8-1.4)
Other 63 (34.6) 119 (65.4)
Total 125 (35.3) 229 (64.7)
No Parent 460 (45.3) 556 (54.7) 45.3%/38.1%=1.2 (0.8-1.8)
Other 16 (38.1) 26 (61.9)
Total 476 (45.0) 582 (55.0)
Vaccination of hepatitis A (%)
Yes No
Table 5. Calculation of relative prevalence after stratifying by mother’s employment; observed association of primary caregiver and
vaccination of hepatitis A was a result of confounding by a mother’s employment6
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